Sex, Age, and Tumor Genetics to Inform Risk Stratification in Papillary Thyroid Cancer - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Influence of Sex, Age, and Tumor Genetics on Risk Assessment in Papillary Thyroid Carcinoma

  • By

  • Carmelo Nucera

  • September 29, 2026

Share

  • 1

    Patient age is a key component of prognostic models for papillary thyroid carcinoma (PTC), influencing disease-specific mortality.

  • 2

    BRAF V600E and TERT promoter mutations are significant determinants of aggressive tumor behavior in PTC.

  • 3

    Male sex is linked to higher mortality in PTC, particularly in tumors with BRAF V600E or TERTp mutations, but not in genetically wild-type tumors.

  • 4

    The interaction of sex and age suggests that prognosis in PTC is shaped by their combined effects rather than independently.

  • 5

    The study advocates for integrating molecular context into clinical risk assessment for PTC, moving beyond traditional demographic variables.

Original Source(s)

Related Content